Out of 22 cases of secretory endometrium
, 16(72.72%) were between 18-39 years, 3(13.63%) were between 40- 50 years and 3(13.63%) were greater than 51 years.
Case 17, an EIN in a background of secretory endometrium
(Figure 4, A and B), and case 11, a variable gland crowding in a secretory endometrium
(Figure 4, C and D), showed agreement with the authors' diagnosis in only 23% and 42% of respondents (18 and 33 of 78 participants), respectively.
Proliferative endometrium, secretory endometrium
, and endometrial hyperplasia without atypia were negative for p53.
Among patients in 31-40 years age group, the most frequent finding was secretory endometrium
in 35.7% patients, followed by disordered proliferative and proliferative phase endometrium in 7% patients each.
And in below 40 age group secretory endometrium
. Anovulatory bleeding was most common in the above 40 age group.
The cause of bleeding in proliferative phase is anovulatory cycles, such cases shows progressive rise of oestrogen to comparatively high levels, which is then followed by sudden fall in oestrogen due to feedback inhibition of pituitary or of FSH secretion and bleeding results and the cause of bleeding in secretory endometrium
is ovulatory dysfunctional uterine bleeding.
Histopathological Endometrial patterns were classified as Proliferative Endometrium (PE), Secretory Endometrium
(SE), Disordered Proliferative Pattern (DPP), Atrophic Endometrium (AE), Endometrial Polyp (EP), Chronic Endometritis (CE), Endometrial Hyperplasia (EH) and Endometrial Carcinoma (CA).
Before starting treatment, mean ET was 7.41 [+ or -] 2.30, endometrial aspiration revealed proliferative endometrium in 63.26%, secretory endometrium
was in 26.53%, simple hyperplasia without atypia was seen in 6.12% and menstrual phase in 4.08%.
Endometrial polyps were found in 9(7.8%) cases, proliferative endometrium was found in 10(8.6%) endometritis was seen in 3(2.6%) cases, secretory endometrium
in (0.9%) case and adenofibroma in 1(0.9%) case.
An inadequate corpus luteum thus formed may lead to formation of an imperfect secretory endometrium
, which may result in abnormal postmenopausal bleeding.
They found proliferative endometrium (62%), secretory endometrium
(20%), hyperplastic endometrium (13%), irregular ripening (1%), and irregular shedding (1%) on histopathological examination (13).
Group 2: Patients with secretory endometrium
: Present study reports secretory endometrium
in 15(15%) cases on hysteroscopy.